Dermal Fillers Market Size, Share, Growth | Report by 2028

The dermal fillers market is projected to reach US$ 9,421.33 million by 2028 from US$ 4,391.98 million in 2021; it is estimated to grow at a CAGR of 11.5% from 2021 to 2028.

Dermal fillers are anti-aging products that are injected into the skin of patients to add volume. They are injected to make the sagging skin or the skin that has become wrinkled because of age look smooth and plump. They are also called injectable facial fillers, injectable cosmetic fillers, or soft tissue fillers. They are made of hyaluronic acid taken from animals or from the fat of the patient. It takes five minutes to an hour to perform dermal filler procedures. Intradermal fillers can be used in dermatological practices with minimal overhead costs. They address the issues such as facial volume loss and dynamic lines, which are the main indications of facial aging. They provide dermatological practitioners with an array of flexible treatment options for balanced and holistic results. An increase in preference for minimally invasive procedures, growth in population belonging to age group 30–65 and rise in consumer attraction toward beauty and wellness are among the main factors fueling the dermal fillers market growth. However, the high cost of surgeries hampers the market growth.

Get more information on this report : Request Free Sample PDF

Market Insights

Increase in Preference for Minimally Invasive Procedures Drives Dermal Fillers Market Growth

In recent years, the adoption of minimally invasive procedures has increased worldwide. A minimally invasive surgery offers patients several benefits such as smaller incisions, faster recovery times, and reduced pain and scarring. Several minimally invasive dermatological techniques have been developed for facial rejuvenation. Injectable dermal fillers are injected into the upper layers of the dermis to treat superficial fine wrinkles or into the deep dermis or subcutaneous space for facial volume augmentation. Dermal fillers are deposited slowly and steadily. They fill central folds, resulting in a natural, long-lasting outcome. Crease depth, desired effect, and patient's financial situation needs to be considered when deciding the quantity of product to be used. According to statistics provided by the American Society of Plastic Surgeons (ASPS), more than 2.7 million dermal filler procedures were performed in 2019. Further, Allergan stated that the unit sales of dermal filler treatments increased by 17% in.

Age plays a significant role in defining the specific needs of medical esthetic procedures; adults more often request minimally invasive methods. Moreover, people aged 35–55 years prefer minimally invasive esthetic procedures over surgery. Plastic surgeons are becoming more willing to explore them, and minimally invasive cosmetic and esthetic procedures are now an established interdisciplinary topic. The rise of non-surgical technologies and new treatment options has made esthetics more accessible to a broader audience. Patients in their 20s and 30s are helping fuel this trend.

Collectively, the benefits and the accuracy of minimally invasive procedures over traditional surgery are expected to drive the dermal fillers market growth in the coming years. With the ever-increasing popularity of nonsurgical enhancement, the demand for fillers continues to rise.

Product-Based Insights

Based on product, the dermal fillers market is segmented into biodegradable and non-biodegradable. In 2021, the biodegradable segment is expected to hold a larger share of the market, and it is expected to register a higher CAGR in the market during the forecast period. Biodegradable fillers include collagens, hyaluronic acids (hyalurons), hydroxylapatite, poly-l-lactic acid (PLLA), and cadaveric tissue. These products are safe and are approved by the FDA. JUVÉDERM VOLUMA XC offered by Allergan plc., is a sterile, biodegradable, non-pyrogenic, viscoelastic, clear, colorless, and homogenized gel implant. In June 2020, FDA approved JUVÉDERM VOLUMA XC for enhancement of the chin area.

Dermal Fillers Market, by Product – 2021 and 2028

Get more information on this report : Request Free Sample PDF

Material-Based Insights

Based on material, the dermal fillers market is segmented into calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polymethylmethacrylate (PMMA), fat, and other materials. The hyaluronic acid segment is expected to hold the largest share of the market in 2021, and the collagen segment is anticipated to register the highest CAGR in the market during the forecast period.

Application-Based Insights

The dermal fillers market, by application, is segmented into facial line correction treatment, lip enhancement, facelift, scar treatment, and others. The facial line correction treatment segment is likely to hold the largest share of the market in 2021, whereas the facelift segment is estimated to register the highest CAGR in the market during the forecast period.

End-User-Based Insights

The dermal fillers market, by end user, is segmented into dermatology clinics, multispecialty hospitals, ambulatory surgical centers, and others. The dermatology clinics segment is estimated to hold the largest market share in 2021. However, the multispecialty hospitals segment is estimated to register the highest CAGR of 12.0% in the market during the forecast period.

Strategic Insights

Various companies operating in the dermal fillers market are adopting strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain brand name, and meet the growing demand from end users.

Dermal Fillers Market – by Product

• Biodegradable
• Non-Biodegradable

Dermal Fillers Market – by Material

• Calcium Hydroxylapatite
• Hyaluronic Acid
• Collagen
• Poly-L-Lactic Acid
• Polymethylmethacrylate (PMMA)
• Fat Fillers
• Other

Dermal Fillers Market – by Application

• Facial Line Correction Treatment
• Lip Enhancement
• Face Lift
• Scar Treatment
• Others

Dermal Fillers Market – by End User

• Dermatology Clinics
• Multispecialty Hospitals
• Ambulatory Surgical Centers
• Others

Dermal Fillers Market – by Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific

• Middle East & Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

• South America (SAM)

  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

• AbbVie, Inc.            
• Galderma               
• Merz Pharma        
• Suneva Medical    
• BIOXIS pharmaceuticals    
• HUADONG MEDICINE CO., LTD       
• BIOPLUS CO., LTD.               
• TEOXANE LABORATORIES                
• BIOHA LABORATORIES      
• Prollenium Medical Technologies